Stockscreener 앱 받기
0.00
100.00%
-5.34
전일 마감가:
$5.34
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$35.98M
수익:
$15.27M
순이익/손실:
$-62.63M
주가수익비율:
0.00
EPS:
-7.3629
순현금흐름:
$-114.74M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$6.95
제너레이션 바이오 Stock (GBIO) Company Profile
명칭
Generation Bio Co
전화
857-529-5908
주소
301 BINNEY STREET, CAMBRIDGE
Compare GBIO vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GBIO
Generation Bio Co
|
0.00 | 35.98M | 15.27M | -62.63M | -114.74M | -7.3629 |
VRTX
Vertex Pharmaceuticals Inc
|
426.54 | 113.59B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
594.64 | 64.45B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
804.37 | 51.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
285.87 | 40.32B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
153.14 | 33.48B | 742.00K | -1.37B | -1.07B | -7.0731 |
제너레이션 바이오 Stock (GBIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-16 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-12-16 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2025-08-13 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2023-10-19 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2022-11-08 | 개시 | Canaccord Genuity | Buy |
| 2021-12-14 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-06-08 | 개시 | JMP Securities | Mkt Outperform |
| 2021-02-24 | 개시 | William Blair | Outperform |
| 2021-02-18 | 개시 | Needham | Buy |
| 2020-07-07 | 개시 | Cowen | Outperform |
| 2020-07-07 | 개시 | JP Morgan | Overweight |
| 2020-07-07 | 개시 | Jefferies | Buy |
| 2020-07-07 | 개시 | Wedbush | Outperform |
모두보기
제너레이션 바이오 주식(GBIO)의 최신 뉴스
Samsung will create the "Samsung Life Science Fund No. 3" worth 200 billion won to expand investment.. - 매일경제
Massive Bio Announces Next-Generation Reticulum Nexus™ Product Suite at ASCO 2026 - 01net
Generation Bio Co stock (US37148B1061): Eli Lilly deal fuels fresh attention on DNA-delivery special - AD HOC NEWS
Generation Bio stock (US37148B1061): Trial momentum keeps investors watching - AD HOC NEWS
Generation Bio stock: Trial momentum keeps investors watching - AD HOC NEWS
Organic wastes to next-generation bioplastics through intelligent biomanufacturing of polyhydroxyalkanoates - Nature
Cosmax China unveils next-generation bio beauty solutions at China Expo - theinvestor.co.kr
Atlas Venture amends 13G/A on GBIO holdings (GBIO) - Stock Titan
TradingKey - TradingKey
ParcelBio Launches with $13 Million in Financing to Advance Next-Generation mRNA Medicines - Business Wire
Samsung Bioepis announced on the 29th that it will sign a memorandum of understanding (MOU) with the.. - 매일경제
XOMA (XOMA) closes Generation Bio acquisition, details cash-plus-CVR terms and LNP assets - Stock Titan
Generation Bio Co. (GBIO) Reports Q1 Loss, Tops Revenue Estimates - MSN
Firm secures £100k to develop next generation plastics - The Argus
Low-energy path to bioplastics emerges from discarded wood - The Korea Times
Eli Lilly acquires Houston biotech startup for $300M - Houston Chronicle
CrossBridge Bio Enters an Agreement to be Acquired by Eli Lilly to Advance Next-Generation Dual-Payload Antibody-Drug Conjugates - Business Wire
National Growth Fund Invests in SK Bioscience… Supporting Next-Generation Bio and Vaccine Development - Seoul Economic Daily
Retail Trends: Why is Generation Bio Co stock going downQuarterly Profit Summary & Safe Entry Momentum Stock Tips - baoquankhu1.vn
GBIO SEC FilingsGeneration Bio Co. 10-K, 10-Q, 8-K Forms - Stock Titan
Fed Meeting: Will Generation Bio Co benefit from AI trends2026 Rallies & Expert-Curated Trade Recommendations - baoquankhu1.vn
Sell Signal: Will Generation Bio Co benefit from AI trends2026 Analyst Calls & Smart Investment Allocation Tips - baoquankhu1.vn
Generation Bio Co stock: Why this gene therapy innovator merits your watchlist now - AD HOC NEWS
XOMA SEC FilingsXOMA Royalty Corporation 10-K, 10-Q, 8-K Forms - Stock Titan
Investment Report: Whats the beta of Generation Bio Co stock2026 Geopolitical Influence & AI Driven Price Forecasts - baoquankhu1.vn
If You Invested $1,000 in Generation Bio Co. (GBIO) - Stock Titan
Wedbush Downgrades Generation Bio (GBIO) - MSN
Aug Spikes: Whats the beta of Generation Bio Co stockWeekly Loss Report & Safe Entry Point Identification - baoquankhu1.vn
Jefferies downgrades Generation Bio (GBIO) - MSN
Samsung Bioepis Enters into Partnership Agreement with Sandoz for Up to Five Next-Generation Biosimilar Candidates - Businesskorea
Will Generation Bio Co benefit from green energy policiesTrade Exit Report & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
How interest rate cuts could boost Generation Bio Co. stockDividend Hike & AI Based Trade Execution Alerts - Naître et grandir
Performance Recap: Can Generation Bio Co grow without external fundingMarket Growth Report & Free Community Consensus Stock Picks - baoquankhu1.vn
Universidade de Aveiro - Universidade de Aveiro
Generation Bio (GBIO) to Release Earnings on Thursday - Defense World
Sironix Renewables Launches Furasoft™Next Generation, Bio-Based Surfactant for Personal Care - The Manila Times
Generation Bio Co. (NASDAQ:GBIO) Receives Average Recommendation of “Hold” from Brokerages - Defense World
GBIO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Borrowing from biology to power next-gen data storage - The Pennsylvania State University
MegazoneCloud to work with CellKey AI on global business for bio AI solutions - 디지털투데이
[15-12G] Generation Bio Co. SEC Filing - Stock Titan
T. Rowe Price holds 3.1% of Generation Bio (GBIO) shares - Stock Titan
Will Generation Bio Co. benefit from green energy policiesJuly 2025 Sector Moves & Daily Volume Surge Trade Alerts - mfd.ru
Generation Bio (NASDAQ:GBIO) Stock Rating Upgraded by Wall Street Zen - Defense World
Xoma stock rating reinstated as Hold by TD Cowen after Generation Bio acquisition - Investing.com Australia
Bear Alert: Why is Generation Bio Co. stock going downJuly 2025 Analyst Calls & Stock Portfolio Risk Management - mfd.ru
제너레이션 바이오 (GBIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.35%
자본화:
|
볼륨(24시간):